Centessa Pharmaceuticals to Present Preclinical Data for

Oral presentation to include preclinical profile for ORX750, Centessa’s first orexin agonist development candidate for the treatment of narcolepsy and...

Related Keywords

London ,City Of ,United Kingdom ,Boston ,Massachusetts ,United States ,Russia ,Rio De Janeiro ,Estado Do Rio ,Brazil ,Ukraine ,David Grainger ,Kristenk Sheppard ,Karl Gibson ,Saurabh Saha ,Emiliangelo Ratti ,Mario Alberto Accardi ,Gregoryr Ott ,Deborahs Hartman ,Thomass Kilduff ,Tod Steinfeld ,Nasdaq ,Centessa Pharmaceuticals ,Exchange Commission ,World Sleep Congress ,Sarah Wurts Black ,Chief Executive Officer ,Co Chairs Sarah Wurts Black ,Symposium Abstract ,Sarah Wurts ,Annual Report ,Quarterly Reports ,Nasdaq Cnta ,Centessa Pharmaceuticals Plc ,